FDA approves generic Wellbutrin SR from Sun Pharma unit

04/8/2010 | Bloomberg Businessweek

The FDA approved a generic version of GlaxoSmithKline's antidepressant Wellbutrin SR. The approval covers 100-, 150- and 200-milligram tablets of bupropion hydrochloride, to be marketed by a subsidiary of Sun Pharmaceutical Industries.

View Full Article in:

Bloomberg Businessweek